Phase I – Other

1,082 trials 241 recruiting

Filter these 1,082 trials by condition, country, sponsor and more.

Open in Search →

Three-part PK and PD study of AXN-027 Recruiting

2025-524019-35-00 Chronic pain, refractory epilepsy, and other neurologic 2026-06-29
A trial in healthy participants to find out how long JNJ-101556143 stays in and acts on the body when administered as different formulations… Recruiting

2026-526263-38-00 Prostate Cancer 2026-06-19
A study in healthy men to test how bosentan influences the amount of zongertinib in the blood Recruiting

2025-523193-16-00 Healthy volunteer trial 2026-06-16
A Safety Study to Test a New Medicine (ANT3310) Alone and When Taken with an Antibiotic (Meropenem) in Healthy Adult Participants. Recruiting

2026-526411-11-00 Not applicable for phase I study 2026-06-15
A Study of Eloralintide (LY3841136) in Participants With Overweight or Obesity Recruiting

2025-523873-41-00 Overweight Obesity 2026-06-09
Safety and Preliminary Efficacy of CTX112 in Adult Participants with Relapsed/Refractory Hematologic Autoimmune Disease Recruiting

2025-523845-90-00 Relapsed/Refractory Hematologic Autoimmune Disease 2026-06-09
Mass Balance and Absolute Oral Bioavailability of [14C]VH4524184 Recruiting

2026-525590-40-00 human immunodeficiency virus (HIV) 2026-06-03
SIE-1 Recruiting

2025-523269-31-00 Hormone receptor-positive early breast cancer in post-m 2026-06-02
Evaluation of AG-181 in Subjects 18 to 69 Years of Age With Phenylketonuria Recruiting

2025-522630-31-00 Phenylketonuria 2026-06-02
A PHASE 1, OPEN-LABEL STUDY TO ASSESS THE ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION, INCLUDING THE MASS BALANCE, OF A SINGLE ORAL … Recruiting

2025-524832-20-00 Healthy volunteers 2026-06-01
Phase 1b Study of Tarlatamab + ZL-1310 +/- Anti-PD-L1 in Small Cell Lung Cancer Recruiting

2025-522888-15-00 Small Cell Lung Cancer 2026-05-27
Phase 1 clinical trial to evaluate the safety, tolerability, and pharmacokinetics of intravenous single ascending doses of IM-250 in healthy… Recruiting

2025-523146-27-00 Herpes simplex virus encephalitis 2026-05-26
Study of diclofenac skin reservoir formation and emptying after Voltaren Emulgel 2.32% application in healthy participants Recruiting

2025-524764-38-00 For the local, symptomatic treatment of pain in acute b 2026-05-26
A study to test how well different doses of BI 3820768 are tolerated by people with advanced cancer (solid tumours) Recruiting

2025-522913-45-00 Advanced relapsed or refractory ovarian cancer 2026-05-21
Multiple Dose Study of RO7795068 and its effect on Gastric Emptying, and on PK of Oral Contraceptives Recruiting

2025-524052-58-00 Healthy Overweight or Obese 2026-05-21
A Randomized Study in Healthy Participants to Identify the Optimal Subcutaneous Injection Strategy for COR-1167 Recruiting

2026-526096-31-00 Chronic Heart Failure 2026-05-20
A Single-Dose Pharmacokinetic Study of Eloralintide in Participants with Varying Degrees of Liver Impairment and Participants with Normal Li… Recruiting

2025-523847-36-00 Participants with Mild, Moderate, or Severe Hepatic Imp 2026-05-19
PHARMACOKINETICS OF PETRELINTIDE FOLLOWING ADMINISTRATION TO PARTICIPANTS WITH IMPAIRED HEPATIC FUNCTION Recruiting

2025-523641-10-00 Healthy / hepatic impaired volunteers only study to ass 2026-05-18
A study to learn more about the safety and effects of a new blood-thinning medicine, given alone and together with another blood-thinner, in… Recruiting

2025-524043-12-00 atrial fibrillation 2026-05-13
A research study looking into blood levels of the medicine NNC0487 0111 in the body and how well it is tolerated in people with reduced live… Recruiting

2025-521647-20-00 hepatic impairment 2026-05-12
A randomised, open-label, single-centre, drug-drug-interaction trial to evaluate the impact of carboxylesterase 2 (CES2)- and CYP3A4-inhibit… Recruiting

2026-526135-18-00 Idiopathic pulmonary fibrosis 2026-05-12
Effect of NBI-921355 on corticospinal excitability in healthy participants Recruiting

2025-524134-26-00 Epilepsy 2026-05-08
Allogeneic adipose tissue derived-stem cells in Alzheimer disease Recruiting

2022-502846-28-00 Alzheimer 2026-05-07
GRT-1C102: A randomized, double-blind, placebo-controlled dose escalation study to evaluate the safety, tolerability, and pharmacokinetics/p… Recruiting

2025-524328-24-00 Ulcerative colitis 2026-05-06